The Hidden Pandemic of COVID-19-Induced Organizing Pneumonia
Since the beginning of the COVID-19 pandemic, clinical, radiological, and histopathological studies have provided evidence that organizing pneumonia is a possible consequence of the SARS-CoV2 infection. This post-COVID-19 organizing pneumonia (PCOP) causes persisting dyspnea, impaired pulmonary func...
Main Authors: | Evgeny Bazdyrev, Maria Panova, Valeria Zherebtsova, Alexandra Burdenkova, Ivan Grishagin, Fedor Novikov, Vladimir Nebolsin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/12/1574 |
Similar Items
-
Clinical features and predictors for patients with severe SARS-CoV-2 pneumonia at the start of the pandemic: a retrospective multicenter cohort study
by: Chao Cao, et al.
Published: (2021-07-01) -
Adjunctive corticosteroid therapy for inpatients with Mycoplasma pneumoniae pneumonia
by: Masato Tashiro, et al.
Published: (2017-12-01) -
Impairment of Social-Related Quality of Life in COVID-19 Pneumonia Survivors: A Prospective Longitudinal Study
by: Takahiro Ando, et al.
Published: (2023-12-01) -
Corticosteroids for all adult patients with community-acquired pneumonia?
by: Ger Rijkers, et al.
Published: (2015-01-01) -
Combination treatment of short-course systemic corticosteroid and favipiravir in a successfully treated case of critically ill COVID-19 pneumonia with COPD
by: Hideki Inoue, et al.
Published: (2020-01-01)